Industry-Sponsored Symposium - Partnering With Patients: Personalizing Care for IBS-C

Brooks D. Cash, MD, FACG, Amol Sharma, MD, FACG

This program is supported by an independent educational grant from Ardelyx.

Irritable bowel syndrome with constipation (IBS-C) is a chronic disease that substantially impacts patients’ physical and psychosocial well-being. Many patients go years before being diagnosed, and a significant proportion remain undiagnosed and untreated. In this live symposium, expert faculty will discuss the latest clinical evidence and best practices for the diagnosis and treatment of IBS-C. Presentations will be aided by a clinical whiteboard to illustrate key concepts in the complex pathophysiology of IBS-C that can now be targeted by FDA-approved treatments. In addition, a patient with IBS-C will join the panel and provide her perspective on the diagnostic and treatment journey, as well as tips for improving dialogue with patients to optimize care of patients with this burdensome condition.

A recording of this presentation will be available to all ACG 2022 attendees on the ACG Conference Platform after the live session through March 31, 2023.

Open to all ACG 2022 attendees, industry-sponsored symposia provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.